89 search results for: pediatric

Breaking the Cycle of AD in Adults: Minimizing Cumulative Burden Beyond Skin and Achieving Sustained Disease Control
Dermatology
Breaking the Cycle of AD in Adults: Minimizing Cumulative Burden Beyond Skin and Achieving Sustained Disease Control
expert video

Prof. Tilo Biedermann discusses the key roles of type 2 cytokines IL-4, IL-13, and IL-31 in the pathophysiology of atopic dermatitis. He then describes how these cytokines can be targeted with systemic therapies to elicit long-term disease control and reduce the burden of atopic and non-atopic comorbidities, which are meaningful outcomes for patients with uncontrolled disease.

View more
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a Patient's Life
Dermatology
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a Patient's Life
expert video

Dr. Nicole Chase describes a potential hypothesis for the link between the shift to an industrialized society and the rise in type 2 inflammatory diseases, highlighting the loss of immunomodulatory mechanisms driven by helminthic infections. She explains how unopposed immune responses to common environmental allergens may cause chronic type 2 inflammation, manifesting throughout the body.

View more
World Lung Day 2024
Awareness Day
25
September
2024
Awareness Day
World Lung Day 2024

September 25th marks this year’s observance and celebration of World Lung Day!

AFRS Disease Burden Infographic
Rhinology
AFRS Disease Burden Infographic
Infographic

This infographic highlights the clinical burden of Allergic Fungal Rhinosinusitis (AFRS), including disease severity, recurrence, complications, and impact on patients compared with CRSwNP.

View more
ADVENT at EADV 2026
Congress
29
September
2026
Congress
ADVENT at EADV 2026

Please join the ADVENT program at EADV 2026 for educational sessions on AD, PN, and CSU! Experience 3 high-impact sessions led by world-renowned experts, bridging scientific innovation with real-world clinical outcomes.